Tango Therapeutics, Inc. (TNGX)
29.80
+1.12
(+3.92%)
USD |
NASDAQ |
Jun 11, 16:00
29.68
-0.12
(-0.42%)
After-Hours: 20:00
Tango Therapeutics Max Drawdown (5Y) : 93.64% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 93.64% |
| April 30, 2026 | 93.64% |
| March 31, 2026 | 93.64% |
| February 28, 2026 | 93.64% |
| January 31, 2026 | 93.64% |
| December 31, 2025 | 93.64% |
| November 30, 2025 | 93.64% |
| October 31, 2025 | 93.64% |
| September 30, 2025 | 93.64% |
| August 31, 2025 | 93.64% |
| July 31, 2025 | 93.64% |
| June 30, 2025 | 93.64% |
| May 31, 2025 | 93.64% |
| April 30, 2025 | 93.01% |
| March 31, 2025 | 92.08% |
| February 28, 2025 | 88.03% |
| January 31, 2025 | 84.86% |
| December 31, 2024 | 84.57% |
| November 30, 2024 | 84.57% |
| October 31, 2024 | 84.57% |
| September 30, 2024 | 84.57% |
| August 31, 2024 | 84.57% |
| July 31, 2024 | 84.57% |
| June 30, 2024 | 84.57% |
| May 31, 2024 | 84.57% |
| Date | Value |
|---|---|
| April 30, 2024 | 84.57% |
| March 31, 2024 | 84.57% |
| February 29, 2024 | 84.57% |
| January 31, 2024 | 84.57% |
| December 31, 2023 | 84.57% |
| November 30, 2023 | 84.57% |
| October 31, 2023 | 84.57% |
| September 30, 2023 | 84.57% |
| August 31, 2023 | 84.57% |
| July 31, 2023 | 84.57% |
| June 30, 2023 | 84.57% |
| May 31, 2023 | 84.39% |
| April 30, 2023 | 81.21% |
| March 31, 2023 | 81.21% |
| February 28, 2023 | 81.21% |
| January 31, 2023 | 81.21% |
| December 31, 2022 | 81.21% |
| November 30, 2022 | 81.21% |
| October 31, 2022 | 81.21% |
| September 30, 2022 | 81.21% |
| August 31, 2022 | 77.98% |
| July 31, 2022 | 77.69% |
| June 30, 2022 | 77.69% |
| May 31, 2022 | 73.18% |
| April 30, 2022 | 60.35% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Revolution Medicines, Inc. | 73.29% |
| Erasca, Inc. | -- |
| Kymera Therapeutics, Inc. | 87.51% |
| NovelStem International Corp. | 97.80% |
| Brainstorm Cell Therapeutics, Inc. | 43.45% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -1.675 |
| Beta (5Y) | 1.185 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 136.8% |
| Historical Sharpe Ratio (5Y) | 0.0797 |
| Historical Sortino (5Y) | 0.2767 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.00% |